WGRX
Wellgistics Health, Inc.
$3.07
+0.12 (+4.07%)
At close · Jul 10
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern within twelve months from the date these unaudited condensed consolidated financial statements are issued.”View the 10-Q filed May 19, 2026
Market Cap
$385.81M
Shares
125,671,251
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$23.34M
+28.7%
FY2025
Net Income
-$101.27M
-1377.1%
FY2025
Gross Margin
-27.54%
-37.3pp
FY2025
Operating Margin
-401.7%
-367.8pp
FY2025
Diluted EPS
-$71.50
-853.3%
FY2025
Operating Cash Flow
-$10.86M
-786.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| $14.03M | $23.34M | $18.13M | |
| $20.98M | $29.76M | $16.36M | |
| -$6.95M | -$6.43M | $1.77M | |
| — | -27.54% | 9.75% | |
| $2.12M | $1.22M | — | |
| $44.03M | $70.33M | $6.8M | |
| $49.23K | $49.23K | $26.84K | |
| $2.77M | $3.21M | $1.11M | |
| $61.47M | $87.32M | $7.91M | |
| -$68.42M | -$93.75M | -$6.15M | |
| — | -401.7% | -33.9% | |
| -$65.65M | -$90.54M | -$5.03M | |
| $5.56M | $4.58M | $831.47K | |
| -$8.17M | -$7.53M | -$711.09K | |
| -$76.59M | -$101.27M | -$6.86M | |
| -$76.59M | -$101.27M | -$6.86M | |
| — | -433.95% | -37.82% | |
| USD/shares | — | -$71.50 | -$7.50 |
| USD/shares | — | -$71.50 | -$7.50 |
| shares | — | 1.42M | 945.04K |
| shares | — | 1.42M | 945.04K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
30.55×
EV/EBIT
—
P/E (TTM)
—
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Product | $21,868,748 | $17,669,468 |
| Pharmacy Retail Sales | $865,695 | $352,363 |
| Third Party Logistics Services | $603,417 | $107,000 |